...
机译:评估炎症性肠病患者6-硫鸟嘌呤相关肝毒性的系统调查
Medical University of Vienna, Austria;
Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart, and University of Tübingen, Germany;
Leiden University Medical Center, Leiden, The Netherlands;
Division of Gastroenterology and Hepatology/IMK, Link?ping university, Sweden;
Charles University, Prague, Czech Republic;
Krankenhaus Rudolfstiftung, Vienna, Austria;
Mater Health Services' Adult Hospital, South Brisbane, Australia;
University-Hospital Munich-Gro?hadern, Munich, Germany;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
Medical University of Vienna, Austria;
6; thioguanine; Drug; induced liver injury; Inflammatory bowel disease; Nodular regenerative hyperplasia; Thiopurines;
机译:炎症性肠病患者免疫策略的知识与应用:炎症性肠病研究中的意大利人群调查
机译:炎症性肠病患者工作残障的危险因素-荷兰基于网络的全国性调查。炎症性肠病的工作障碍。
机译:诊断为炎症性肠病的年龄会影响炎症性肠病患者大肠癌的早期发展:一项全国性的长期调查。
机译:炎症性肠病患者的发病率增加了与免疫调节治疗有关的发病危险
机译:肠道制剂对健康受试者中结肠菌细菌植物菌的影响和炎症性肠病患者
机译:诊断为炎症性肠病的年龄影响炎症性肠病患者大肠癌的早期发展:一项全国性的长期调查
机译:P801医生对炎症性肠病患者免疫策略的知识和应用:意大利小组研究炎症性肠病患者的调查(IG-IBD)